Glecaprevir-pibrentasvir for 4 weeks among people with recent HCV infection: The TARGET3D study

Background & Aims: Short duration treatment may aid HCV elimination among key populations. This study evaluated the efficacy of glecaprevir-pibrentasvir for 4 weeks among people with recent HCV infection. Methods: In this single-arm multicentre international trial, adults with recent HCV (durati...

Descripció completa

Dades bibliogràfiques

Autors principals:	Marianne Martinello, Sanjay Bhagani, David Shaw, Chloe Orkin, Graham Cooke, Edward Gane, David Iser, Andrew Ustianowski, Ranjababu Kulasegaram, Catherine Stedman, Elise Tu, Jason Grebely, Gregory J. Dore, Mark Nelson, Gail V. Matthews
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2023-10-01
Col·lecció:	JHEP Reports
Matèries:	Hepatitis C acute recent direct-acting antiviral treatment
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S2589555923001982
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!